Barrett John A 4
4 · Molecular Insight Pharmaceuticals, Inc. · Filed May 14, 2009
Insider Transaction Report
Form 4
Barrett John A
Sr. V.P. of Preclinical Dev
Transactions
- Award
Employee Stock Option (right to buy)
2009-05-12+12,500→ 12,500 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (12,500 underlying) - Award
Employee Stock Option (right to buy)
2009-05-12+7,500→ 7,500 totalExercise: $3.93Exp: 2019-05-12→ Common Stock (7,500 underlying)
Footnotes (2)
- [F1]This option vests and becomes exercisable in four equal annual installments of 3,125 shares each, beginning on May 12, 2010.
- [F2]This option vests and becomes exercisable in two equal annual installments of 3,750 shares each, beginning on May 12, 2010.